Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start (A3921069). Pfizer Inc. (NYSE:PFE) stock opened at $31.99 in last session, and closed at $31.99, while the day range of stock is $31.53 – $32.08. The stock showed a positive weekly performance of 0.16%.
Inovio Pharmaceuticals Inc (NYSEMKT:INO)’s trading in the previous week was characterized with gains on the browser. The stock gained more than 11 percent in the regular session to touch $3.22 per share. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock opened at $3.40, in last session and closed at $ 3.72, by gaining 15.53%. The 52 week range of the stock is $0.49 – $3.95. Company’s market capitalization is $775.16 million.
Merck & Co., Inc. (NYSE:MRK) is not in its very best position at the moment. The company’s forecast implies possible revenue decline of about 3 percent this year. This is due to lack of significant product launches and competition from generic drug manufacturers. Merck & Co., Inc. (NYSE:MRK) stock advanced 0.27% and finished the last session at $56.18. The EPS of the stock remained 1.48. Company’s market capitalization is $164.42 billion.
Shares of MannKind Corp. (NASDAQ:MNKD) saw unusually large options trading activity on Monday. Stock traders acquired 12,443 call options on the stock, Stock Ratings Network reports. MannKind Corporation (NASDAQ:MNKD) stock opened the session at $6.08, and closed the session at $6.40. The 52 week range of the stock remained $2.48 – $8.70 and the day range was $6.06 – $6.50.
Leave a Reply